• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康兔组织中白细胞介素-1受体拮抗剂的检测与特性分析:白细胞介素-1受体拮抗剂可能与健康有关。

Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.

作者信息

Matsukawa A, Fukumoto T, Maeda T, Ohkawara S, Yoshinaga M

机构信息

Department of Pathology, Kumamoto University School of Medicine, Japan.

出版信息

Cytokine. 1997 May;9(5):307-15. doi: 10.1006/cyto.1996.0170.

DOI:10.1006/cyto.1996.0170
PMID:9195129
Abstract

Interleukin 1 (IL-1) is postulated to function in maintaining homeostasis, however, over-action of this cytokine may lead to disruption of homeostasis due to it's wide spectrum of activities. To understand the endogenous regulation of this cytokine, we examined the existence of IL-1 receptor antagonist (IL-1Ra) in tissues from healthy rabbits. IL-1Ra was constitutively produced in all tissues examined (lung, liver, spleen, thymus, caecum, skin, kidney, heart, and brain), as estimated by ELISA. Immunoprecipitation, RT-PCR and immunohistochemical studies indicated that all tissues produced secreted form of IL-1Ra (sIL-1Ra), whereas thymus, caecum, skin and kidney produced both sIL-1Ra and intracellular of IL-1Ra. All tissue IL-1Ra purified using anti-IL-1Ra IgG affinity chromatography had inhibitory activity on the IL-1-induced thymocyte proliferative response, and the activity was totally abolished by anti-IL-1Ra mAb. No IL-1 activity was detected in any tissues except skin and heart, however, after preincubation of the samples with anti-IL-1Ra, the activity was first visible in the tissues. Under these conditions, IL-1 activity in skin and heart was enhanced to 170% and 280%, respectively. Taken together, we conclude that tissue IL-1Ra is involved in health maintenance by masking co-existing IL-1 activity present in tissues.

摘要

白细胞介素1(IL-1)被认为在维持体内平衡中发挥作用,然而,由于这种细胞因子具有广泛的活性,其过度作用可能导致体内平衡的破坏。为了了解这种细胞因子的内源性调节,我们检测了健康兔子组织中白细胞介素1受体拮抗剂(IL-1Ra)的存在情况。通过酶联免疫吸附测定(ELISA)估计,在所检测的所有组织(肺、肝、脾、胸腺、盲肠、皮肤、肾、心脏和脑)中均组成性产生IL-1Ra。免疫沉淀、逆转录聚合酶链反应(RT-PCR)和免疫组织化学研究表明,所有组织均产生分泌形式的IL-1Ra(sIL-1Ra),而胸腺、盲肠、皮肤和肾则同时产生sIL-1Ra和细胞内形式的IL-1Ra。使用抗IL-1Ra IgG亲和层析纯化的所有组织IL-1Ra对IL-1诱导的胸腺细胞增殖反应均具有抑制活性,且该活性被抗IL-1Ra单克隆抗体完全消除。除皮肤和心脏外,在任何组织中均未检测到IL-1活性,然而,在用抗IL-1Ra预孵育样品后,该活性首先在这些组织中显现出来。在这些条件下,皮肤和心脏中的IL-1活性分别增强至170%和280%。综上所述,我们得出结论,组织IL-1Ra通过掩盖组织中同时存在的IL-1活性参与健康维持。

相似文献

1
Detection and characterization of IL-1 receptor antagonist in tissues from healthy rabbits: IL-1 receptor antagonist is probably involved in health.健康兔组织中白细胞介素-1受体拮抗剂的检测与特性分析:白细胞介素-1受体拮抗剂可能与健康有关。
Cytokine. 1997 May;9(5):307-15. doi: 10.1006/cyto.1996.0170.
2
Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.小鼠白细胞介素-1受体拮抗剂亚型:细胞内亚型的互补DNA克隆与蛋白表达以及体内分泌型和细胞内白细胞介素-1受体拮抗剂的组织分布
J Immunol. 1997 Dec 15;159(12):5905-13.
3
Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.可溶性白细胞介素-1受体辅助蛋白通过与白细胞介素-1受体拮抗剂不同的作用方式改善胶原诱导的关节炎。
Arthritis Rheum. 2005 Jul;52(7):2202-11. doi: 10.1002/art.21108.
4
Detection and modulation of interleukin-1 receptor antagonist messenger ribonucleic acid and immunoreactivity in Graves' orbital fibroblasts.格雷夫斯眼眶成纤维细胞中白细胞介素-1受体拮抗剂信使核糖核酸的检测与调控及免疫反应性
Invest Ophthalmol Vis Sci. 1997 Apr;38(5):1018-28.
5
Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.白细胞介素-1受体拮抗剂和白细胞介素-1β基因在抗体介导的肾小球肾炎中的肾小球表达
Am J Pathol. 1994 Jul;145(1):126-36.
6
Characterization of a low molecular weight isoform of IL-1 receptor antagonist.白细胞介素-1受体拮抗剂低分子量异构体的特性分析
J Immunol. 1998 Aug 15;161(4):1997-2003.
7
Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.胶原诱导性关节炎小鼠滑膜中I型细胞内白细胞介素-1受体拮抗剂产生增加:在关节炎消退中的可能作用
Arthritis Rheum. 2001 Feb;44(2):451-62. doi: 10.1002/1529-0131(200102)44:2<451::AID-ANR64>3.0.CO;2-H.
8
Endogenous interleukin-1 receptor antagonist is neuroprotective.内源性白细胞介素-1受体拮抗剂具有神经保护作用。
Biochem Biophys Res Commun. 1997 May 8;234(1):211-5. doi: 10.1006/bbrc.1997.6436.
9
Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.可溶性白细胞介素-1受体与白细胞介素-1α、白细胞介素-1β及白细胞介素-1受体拮抗剂的结合以及滑液中可溶性白细胞介素-1受体的水平
J Immunol. 1994 Nov 15;153(10):4766-74.
10
Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.白细胞介素-1β和白细胞介素-1受体拮抗剂在氧化型低密度脂蛋白处理的人主动脉平滑肌细胞及胆固醇喂养的内皮剥脱兔新生内膜中的表达。
J Cell Biochem. 2003 Mar 1;88(4):836-47. doi: 10.1002/jcb.10431.

引用本文的文献

1
What defines a healthy gut microbiome?健康的肠道微生物组由什么定义?
Gut. 2024 Oct 7;73(11):1893-1908. doi: 10.1136/gutjnl-2024-333378.
2
Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases.白细胞介素-1 家族细胞因子:肝脏炎症性疾病的关键。
Front Immunol. 2019 Aug 27;10:2014. doi: 10.3389/fimmu.2019.02014. eCollection 2019.
3
Altered interleukin-1 receptor antagonist and interleukin-18 mRNA expression in myocardial tissues of patients with dilatated cardiomyopathy.扩张型心肌病患者心肌组织中白细胞介素-1受体拮抗剂和白细胞介素-18信使核糖核酸表达的改变
Mol Med. 2008 Jan-Feb;14(1-2):55-63. doi: 10.2119/2007-00058.Westphal.
4
Increased interleukin-1 (IL-1) and imbalance between IL-1 and IL-1 receptor antagonist during acute inflammation in experimental Shigellosis.实验性志贺氏菌病急性炎症期间白细胞介素-1(IL-1)增加以及IL-1与IL-1受体拮抗剂之间失衡。
Infect Immun. 1999 Nov;67(11):6056-66. doi: 10.1128/IAI.67.11.6056-6066.1999.